It is said that one of the most difficult areas to work on in medicine is the research of new medications and therapies. The pressure to not only come out with a working product is an obstacle in itself, but having to have it approved is a beast all in itself. The Team of Paragon BioScience and it’s leader Jeff Aronin are ready to take this risk for the betterment of the people who are in desperate need of cures. Based in Chicago, Paragon Bioscience is a firm that overseas multiple branches in the pursuit in quickly bringing in new treatments to the world. So far Paragon has been able to achieve an incredible 13 approved drugs, in line with the biggest pharma companies in the country.
Jeff Aronin has recently been leading the charge for a more patient-friendly environment and treatment. So much so that Paragon Bioscience has introduced those who are affected by diseases to their working staff in order to have a team of strong and passionate people. In continuing this pattern, Jeff Aronin has his companies focus on areas where the most patients are and areas where the scarcity of medicine is high.
Paragon Bioscience was built by Jeff Aronin to be different from the pack, to lead in innovation in bringing rapid and effective medicine to those who need it the most, and that is exactly what they are delivering. Their success is not merely accidental, they are a team of highly organized individuals who rely on a three-step process every time they receive a new goal. Understand the patient’s needs, identify novel science to treat the disease and finally, attract the best minds and top investors to rapidly bring effective treatment. Recently under the leadership of Jeff Aronin, Paragon Bioscience will produce some of the only government-approved treatments in the diseases they target.